| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.5 | 0.02 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |